CANNABIDIOL, A FUTURE ANTIBIOTIC?

Pharmotech owns a patent on CBD and composition thereof as antibacterial compound. This first step was achieved in collaboration with the Geneva University. Our goal is to create different new antibiotics for humankind and animals. Soon we will begin the pre-clinical trials on mice and then a clinical. All our R&D is developed in Switzerland in collaboration  with primary medical […]

Read more

Pseudomonas infections are caused by any of several types of the gram-negative bacteria Pseudomonas, especially Pseudomonas aeruginosa.

Pseudomonas aeruginosa and other members of this group of gram-negative bacilli are opportunistic pathogens that frequently cause hospital-acquired infections, particularly in ventilator patients, burn patients, and patients with chronic debility. Many sites can be infected, and infection is usually severe. Diagnosis is by culture. Antibiotic choice varies with the pathogen and must be guided by susceptibility testing because resistance is […]

Read more

Antitumor Effects of Cannabidiol

Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines Daniela ParolaroMaria P. Abbracchio andPaola Massi, Angelo Vaccani, Stefania Ceruti, Arianna Colombo, Abstract Recently, cannabinoids (CBs) have been shown to possess antitumor properties. Because the psychoactivity of cannabinoid compounds limits their medicinal usage, we undertook the present study to evaluate the in vitro antiproliferative ability of cannabidiol (CBD), […]

Read more

Cannabidiol and bone fracture

Cannabidiol improves bone fracture healing in rats Scientists of the Bone Laboratory of Hebrew University of Jerusalem, Israel, reported that the major non-psychoactive cannabis constituent, cannabidiol (CBD), enhances the biomechanical properties of healing bone fractures in rats. The maximal load capacity, but not the stiffness, of thigh bones from rats given a mixture of CBD and THC for 8 weeks […]

Read more

Cannabidiol anticancer

Cannabidiol as potential anticancer drug. Massi P1, Solinas M, Cinquina V, Parolaro D. Abstract Over the past years, several lines of evidence support an antitumourigenic effect of cannabinoids including Δ(9)-tetrahydrocannabinol (Δ(9)-THC), synthetic agonists, endocannabinoids and endocannabinoid transport or degradation inhibitors. Indeed, cannabinoids possess anti-proliferative and pro-apoptotic effects and they are known to interfere with tumour neovascularization, cancer cell migration, adhesion, invasion and metastasization. However, the clinical […]

Read more